BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17716774)

  • 21. Gram-negative pneumonia among patients undergoing dialysis who were admitted to the hospital with angioedema secondary to angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists.
    Sharma M; Johnson LB
    Clin Infect Dis; 2008 Dec; 47(11):1494-5. PubMed ID: 18986269
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of renin-angiotensin-aldosterone system inhibitors within the first eight to twelve weeks after renal transplantation.
    Jennings DL; Taber DJ
    Ann Pharmacother; 2008 Jan; 42(1):116-20. PubMed ID: 18094340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate.
    McMurray J
    BMJ; 2005 May; 330(7502):1269; author reply 1270-1. PubMed ID: 15920134
    [No Abstract]   [Full Text] [Related]  

  • 26. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Taste disturbance by angiotensin-converting enzyme inhibitors/angiotensin-2 receptor blockers.
    Ebihara S; Kohzuki M
    Kidney Int; 2010 Apr; 77(7):649; author reply 649-50. PubMed ID: 20224593
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1740-4. PubMed ID: 19756054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ACE inhibitors and risk of hypoglycemia in people with diabetes.
    Chaturvedi N; Fuller JH
    Diabetes Care; 1998 Mar; 21(3):470-2. PubMed ID: 9540046
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
    Ku E; Park J; Vidhun J; Campese V
    Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of severe hypoglycemia in diabetes patients taking ACE inhibitors.
    Strachan MW; Frier BM
    Diabetes Care; 1998 Mar; 21(3):470; author reply 471-2. PubMed ID: 9540045
    [No Abstract]   [Full Text] [Related]  

  • 34. Guidelines on the management of valvular heart disease.
    Aguiar-Souto P; Mirelis JG; Silva-Melchor L
    Eur Heart J; 2007 May; 28(10):1267; author reply 1267-8. PubMed ID: 17463010
    [No Abstract]   [Full Text] [Related]  

  • 35. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
    Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
    Lonati C; Morganti A
    Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
    [No Abstract]   [Full Text] [Related]  

  • 37. Should angiotensin converting enzyme inhibitors/angiotensin II receptor antagonists be omitted before cardiac surgery to avoid postoperative vasodilation?
    Raja SG; Fida N
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):470-5. PubMed ID: 18272542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Perkins JM; Davis SN
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):147-52. PubMed ID: 18316950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification.
    Maahs DM; Snell-Bergeon JK; Kinney GL; Wadwa RP; Garg S; Ogden LG; Rewers M
    J Diabetes Complications; 2007; 21(5):273-9. PubMed ID: 17825750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.